Categories: Research

Biophysicist James Fraser, PhD, has been named a 2014 Searle Scholar. His laboratory will be awarded $300,000 in funding over the next three years to support his research into more accurately and precisely describing the ways that protein molecules change shape to carry out the functions of life in...

For the 34th consecutive year, the UCSF School of Pharmacy has received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

School researchers were awarded $29.2 million during the 2013 NIH fiscal year, from October 1, 2012 to...

A research team including co-principal investigators Shuvo Roy, PhD, and Mozziyar Etemadi, PhD, who trained in Roy’s lab, has been awarded a three-year $2.7 million grant from the Bill and Melinda Gates Foundation to further develop a remote monitoring and early warning system to reduce premature...

A new analysis of dozens of animal studies evaluating the effects of the cholesterol-lowering statin class of drugs on atherosclerosis found larger positive effects in studies not sponsored by the pharmaceutical industry as compared to those that were industry sponsored.

The UCSF School of Pharmacy has entered into a five-year collaborative education and research agreement with Tsinghua University School of Medicine in Beijing, China.

Zev Gartner, PhD, has been named a recipient of the 2013 National Institutes of Health (NIH) Director’s New Innovator Award, which will provide his lab with up to $1.5 million in research funding over the next five years.

Research led by UCSF scientists has provided fresh insight into the operation of DNA sequences in the genome that regulate gene expression.

In the largest study of its kind to date, researchers led by UCSF scientists found that infants in minority populations who are exposed to motor vehicle air pollution, specifically nitrogen dioxide (NO2), are more likely to develop asthma later in childhood.

Studies of whether patients are taking a blood thinner as prescribed, whether antibiotic treatment of cancer patients’ fevers matches guidelines, and whether one form of a leading cardiovascular drug increases the risk for a serious side effect took top honors at the Department of Clinical Pharmacy...

The San Francisco Chronicle and the Bay Area News Group, which includes the San Jose Mercury News and Oakland Tribune, have published feature articles this week focused on The Kidney Project, an effort to develop the first implantable bioartificial kidney to treat end-stage renal disease.